Article | May 21, 2020

Augmenting BrAIn Power

Source: Oracle Health Sciences

Today clinical operations teams are drowning in data but starving for information, at a time of intense pressure1 to speed clinical trials and restrain costs. The massive volumes of data generated during clinical trials are woefully inadequate at helping stakeholders spot risk factors and bottlenecks that can disrupt cycle times and budgets, primarily due to the inefficient ways in which operational data is captured and analyzed, often relying on outdated methods such as Excel. Excel was not designed to collect and analyze clinical trial data. It lacks project management capability, yet its extensive use persists.2,3

Machine learning has the potential to help by revealing clinical trial patterns, identifying risks and predicting outcomes.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader